Myriad Genetics (NASDAQ:MYGN) Posts Earnings Results, Meets Estimates
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.08) earnings per share for the quarter, meeting the consensus estimate of ($0.08), Briefing.com reports. The company had revenue of $183.50 million during the quarter, compared to the consensus estimate of $187.16 million. Myriad Genetics had a negative […]